BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8734164)

  • 1. Mechanisms and management of congenital and acquired long QT syndromes.
    Lazzara R
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():51-5. PubMed ID: 8734164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome.
    Shimizu W; Ohe T; Kurita T; Kawade M; Arakaki Y; Aihara N; Kamakura S; Kamiya T; Shimomura K
    J Am Coll Cardiol; 1995 Nov; 26(5):1299-309. PubMed ID: 7594047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital and acquired long QT syndromes.
    Walker BD; Krahn AD; Klein GJ; Skanes AC; Wang J; Hegele RA; Yee R
    Can J Cardiol; 2003 Jan; 19(1):76-87. PubMed ID: 12571698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac K+ channels and drug-acquired long QT syndrome.
    Drici MD; Barhanin J
    Therapie; 2000; 55(1):185-93. PubMed ID: 10860023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
    Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
    J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolong QT interval and "torsades de pointes" associated with different group of drugs.
    Gongadze N; Kezeli T; Antelava N
    Georgian Med News; 2007 Dec; (153):45-9. PubMed ID: 18250496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of sudden death in congenital long-QT syndrome].
    Oliveira M; Antunes E; da Silva MN
    Rev Port Cardiol; 1999 Jun; 18(6):627-33. PubMed ID: 10422460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization.
    Cheng JH; Kodama I
    Acta Pharmacol Sin; 2004 Feb; 25(2):137-45. PubMed ID: 14769199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
    Khan IA; Gowda RM
    Int J Cardiol; 2004 May; 95(1):1-6. PubMed ID: 15159030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes.
    Tan HL; Hou CJ; Lauer MR; Sung RJ
    Ann Intern Med; 1995 May; 122(9):701-14. PubMed ID: 7702233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital long QT syndrome].
    Creanza M; van Dam-Koopman IM; Wilde AA; Robles de Medina EO
    Ned Tijdschr Geneeskd; 1997 May; 141(19):926-31. PubMed ID: 9340537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetics of the long QT syndrome: clinical aspects].
    Sepp R; Csanády M
    Orv Hetil; 1999 Nov; 140(47):2633-8. PubMed ID: 10613047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of arrhythmias.
    Janse MJ; Wilde AA
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II41-6. PubMed ID: 9835781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective block of late currents in the DeltaKPQ Na(+) channel mutant by pilsicainide and lidocaine with distinct mechanisms.
    Ono K; Kaku T; Makita N; Kitabatake A; Arita M
    Mol Pharmacol; 2000 Feb; 57(2):392-400. PubMed ID: 10648650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular calcium cycling, early afterdepolarizations, and reentry in simulated long QT syndrome.
    Huffaker R; Lamp ST; Weiss JN; Kogan B
    Heart Rhythm; 2004 Oct; 1(4):441-8. PubMed ID: 15851197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.